May 9th, 2012 - Zurich

How pharma and other stakeholders could work more effectively in generating data in real life to demonstrate attractive cost/benefit ratio

• How can we build win-win-win partnerships to generate clinical and health economic data in the real life,
• What is at stake? (Epidemiology, Safety monitoring, Sustainable market access conditions, medical practice evaluation, HTA, dissemination of innovation….)
• What are innovative practices
• What do we need to efficiently cooperate (patient groups, academic research organizations, scientific societies, health authorities, payers, health care providers and industry)
• What does it take to create trust and move forward?

Participants:

• Susan Knox, European Breast Cancer Coalition..
• A EMA representative
• Philippe Fonjallaz, MerckSerono
• Alex Stojanovic, Grunenthal
• Herve Drevot